Skip to content

Delamanid

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: deltyba, OPC-67683

EMA approvedPMDA approvedATC J04AK06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Delamanid is a drug catalogued in DrugCentral. It was first approved by the EMA in 2013. Recorded indications include Drug resistant tuberculosis.

  • Indications: Drug resistant tuberculosis.
  • ATC code: J04AK06 (Other drugs for treatment of tuberculosis).
  • Molecular formula: C25H25F3N4O6; molecular weight 534.49 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Drug resistant tuberculosis

Regulatory approvals (2)

DateAgencyMarketed asApplicantOrphan
2014-07-04PMDA——
2013-11-22EMA——

ATC classification

ATC codeTherapeutic hierarchy
J04AK06ANTIINFECTIVES FOR SYSTEMIC USE › ANTIMYCOBACTERIALS › DRUGS FOR TREATMENT OF TUBERCULOSIS › Other drugs for treatment of tuberculosis

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Electrocardiogram QT prolonged680.3
Neuropathy peripheral276.4
Anaemia213.3
Incorrect product administration duration128.4
Vomiting128.2
Off label use115.3
Tuberculosis107.5
Intentional product use issue88.8
Hypokalaemia86.4
Optic neuritis79.5
Psychotic disorder71.3
Drug resistance70.2

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Delamanid is on its molecule page.

Molecular formulaC25H25F3N4O6
Molecular weight534.49 g/mol
CAS number681492-22-8
InChIKeyXDAOLTSRNUSPPH-XMMPIXPASA-N
PubChem CID6480466
C[C@]1(COC2=CC=C(C=C2)N2CCC(CC2)OC2=CC=C(OC(F)(F)F)C=C2)CN2C=C(N=C2O1)[N+]([O-])=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Delamanid used for?

DrugCentral lists the following indications for Delamanid: Drug resistant tuberculosis.

When was Delamanid first approved?

Delamanid was first approved by the EMA in 2013.

What is the chemical formula of Delamanid?

Delamanid has the molecular formula C25H25F3N4O6 and a molecular weight of 534.49 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2013-11-22
AgencyEMA
Targets0
Indications1
FormulaC25H25F3N4O6
DrugCentral ID4819
Interactive profile